CrushSCI.com
113.4Average days
107Median days
41Fastest days
193Longest days
3,4532025 publications

Paper Review Records

All Paper Review Records

15 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

193 days

IAP inhibition enhances response to radiotherapy and chemotherapy in preclinical models of rectal cancer

Authors
Timothy O’Brien; Thomas Wright; Matilda Downs; Shaun Sharkey; Catherine Higgins; Jaine Blayney; Fiza M.F. Ishaqwala; Liang Tang; Ashley K. McCulloch; Chia Y. Kong; Lily V.S. Hillson; Ross K. McMahon; Sean M. O’Cathail; Kathryn Pennel; Joanne Edwards; Karl Butterworth; Tomoko Smyth; George Ward; Melissa LaBonte-Wilson; Simon McDade; Catherine Hanna; Campbell Roxburgh; Victoria M. Coyle; Daniel B LongleyShow moreShow less
Affiliations
Johnston Cancer Research Centre, Queen’s University Belfast, Northern Ireland, UK; School of Cancer Sciences, University of Glasgow, Wolfson Wohl Cancer Research Centre, Glasgow, Scotland, UK; Astex Pharmaceuticals, Cambridge, UKShow moreShow less
Source PDF DOI Publisher page
160 days

Sexual dysfunction in men after radiotherapy for squamous cell carcinoma of the Anus: A danish anal cancer group DACG study

Authors
Mette J. Krogstrup; Johanne H. Steffensen; Eva Serup-Hansen; Camilla J.S. Kronborg; Karen-Lise G. SpindlerShow moreShow less
Affiliations
Department of Experimental Clinical Oncology, Department of Oncology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus, 8200, Denmark; Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Boulevard 99, Aarhus N, 8200, Denmark; Department of Oncology, Copenhagen University Hospital – Herlev and Gentofte, Borgmester Ib Juuls Vej 9, Herlev, 2730, Denmark; Danish Centre for Particle Therapy, Aarhus University Hospital, Palle Juul-Jensens Boulevard 25, Aarhus N, DK-8200, Denmark; Department of Oncology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus, 8200, DenmarkShow moreShow less
Source PDF DOI Publisher page
70 days

Cognitive outcomes of low-dose whole-brain radiation therapy in mild Alzheimer's disease: A multicenter, randomized, sham-controlled phase II clinical trial

Authors
Eun-Hee Hong; Aryun Kim; Keun You Kim; Hak Young Rhee; Dong-Ick Shin; Ji Young Kim; Seong-Jun Cho; Dong-Yun Kim; Geon-Ho Jahng; Hyo Been Lee; Woo-Yoon Park; Byoung Hyuck Kim; Weon Kuu ChungShow moreShow less
Affiliations
Radiation Effects Research Section, Radiation Health Institute, Korea Hydro & Nuclear Power Co., Ltd., Seoul, the Republic of Korea; Department of Neurology, College of Medicine, Chungbuk National University, Cheongju, the Republic of Korea; Department of Psychiatry, Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul, the Republic of Korea; Department of Neurology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, the Republic of Korea; Department of Radiation Oncology, Korea University College of Medicine, Korea University Anam Hospital, Seoul, the Republic of Korea; Department of Radiology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, the Republic of Korea; Healthcare Big Data Center, Medical Science Research Institute, Kyung Hee University Hospital at Gangdong, Seoul, the Republic of Korea; Department of Radiation Oncology, College of Medicine, Chungbuk National University, Cheongju, the Republic of Korea; Department of Radiation Oncology, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, the Republic of Korea; Department of Radiation Oncology, Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine, Seoul, the Republic of KoreaShow moreShow less
Source PDF DOI Publisher page
80 days

DAG-informed analysis of muscle characteristics and overall survival in patients receiving radical treatment for bladder cancer

Authors
Alexander J. Vickers; Donal M. McSweeney; Ananya Choudhury; Jamie Weaver; Craig Jones; James Dyer; Gareth Price; Alan McWilliamShow moreShow less
Affiliations
The Christie NHS Foundation Trust, Manchester, United Kingdom; Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine & Health, University of Manchester, Manchester, United Kingdom; Stockport NHS Foundation Trust, Stockport, United KingdomShow moreShow less
Source PDF DOI Publisher page
63 days

Repeated metastasis-directed radiotherapy in patients with oligorecurrent prostate cancer: outcomes and risk stratification from a large multinational PSMA PET-guided cohort

Authors
Ruth van der Walle; Tessa D. van Bergen; Marcin Miszczyk; Max Peters; Mateusz Bilski; Giulio Francolini; Pietro Garlatti; Maris Mezeckis; Justyna Kociolek; Frederik R. Teunissen; Paulien G. Westhoff; Arthur J.A.T. Braat; Cornelis A.T. van den Berg; Shahrokh F. Shariat; Wietse S.C. Eppinga; Shafak Aluwini; Timo F.W. SoeterikShow moreShow less
Affiliations
University Medical Centre Groningen, Dept. Of Radiation Oncology, Groningen, The Netherlands; Computational Imaging Group for MR Diagnostics and Therapy, Center for Image Sciences, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Collegium Medicum – Faculty of Medicine, WSB University, Dąbrowa Górnicza, Poland; Department of Radiation Oncology, Radiotherapiegroep, Deventer, The Netherlands; Radiotherapy Department, Affidea Nu-med Center of Oncological Diagnostics and Therapy, Zamosc, Poland; Clinics of Radiotherapy, Medical University of Lublin, Poland; Department of Radiation Oncology, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy; University of Latvia, Sigulda Hospital Centre of Stereotactic Radiosurgery, Sigulda, Latvia; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands; University Medical Centre Utrecht, Dept. of Nuclear Medicine, Utrecht, The Netherlands; University Medical Centre Utrecht, Dept. of Radiation Oncology, Utrecht, The Netherlands; Department of Urology, University of Texas Southwestern, Dallas, USA; Hourani Center for Applied Scientific Research, l-Ahliyya Amman University, Amman, JordanShow moreShow less
Source PDF DOI Publisher page
168 days

Parametric delineation of the clinical target volume for glioma: Model-based approach that tailors to physician contouring practices

Authors
Gregory Buti; Ali Ajdari; Christopher Bridge; Ariel E. Marciscano; Gregory C. Sharp; Kevin Oh; Fredrik Löfman; Helen A. Shih; Thomas BortfeldShow moreShow less
Affiliations
Massachusetts General Hospital/Mass General Brigham and Harvard Medical School, Department of Radiation Oncology, 100 Blossom St, Boston, MA 02114, USA; Massachusetts General Hospital/Mass General Brigham and Harvard Medical School, Athinoula A. Martinos Center for Biomedical Imaging, 149 Thirteenth St, Charlestown, MA 02129, USA; RaySearch Laboratories AB, Eugeniavägen 18C, SE-104 30 Stockholm, Sweden; Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Ave, Boston, MA 02215, USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does RADIOTHERAPY AND ONCOLOGY take to review a manuscript?

As of 2026-11-13, CrushSCI has 15 complete review records for RADIOTHERAPY AND ONCOLOGY. The fastest paper went from submission to acceptance in 41 days (When progression-free survival fails to inform: the need for event-level reporting in oligometastatic radiotherapy trials, received 2026-07-13, accepted 2026-08-23); the slowest took 193 days. The average is 113.4 days and the median is 107 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.